LY-5 (Nationwide Children's Hospital)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLY-5 (Nationwide Children's Hospital)
Drug Alias NameSTAT3-selective inhibitor (Nationwide Children's Hospital)LY-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsMedulloblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNationwide Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNationwide Children'S Hospital
Active IndicationsN/A
Inactive IndicationsMedulloblastoma

Other Information

ATC CodeN/A
Related LinksN/A